erlotinib hydrochloride has been researched along with 3,3',4,5'-tetrahydroxystilbene in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (3,3',4,5'-tetrahydroxystilbene) | Trials (3,3',4,5'-tetrahydroxystilbene) | Recent Studies (post-2010) (3,3',4,5'-tetrahydroxystilbene) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 547 | 2 | 298 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | 3,3',4,5'-tetrahydroxystilbene (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 5 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 0.67 | |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | 10 | |
| Lactoylglutathione lyase | Homo sapiens (human) | 0.76 | |
| large T antigen | Betapolyomavirus macacae | 16.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, NR; Efferth, T; Gebhart, E; Konkimalla, VB; Suhas, VL | 1 |
| Adès, L; Boehrer, S; Bouteloup, C; de Botton, S; Fenaux, P; Galluzzi, L; Gardin, C; Harper, F; Kroemer, G; Lainey, E; Pierron, G; Sébert, M; Tailler, M; Thépot, S | 1 |
1 review(s) available for erlotinib hydrochloride and 3,3',4,5'-tetrahydroxystilbene
| Article | Year |
|---|---|
Diagnosis and therapy of oral squamous cell carcinoma.
Topics: Age Factors; Alcohol Drinking; Antineoplastic Agents; Aporphines; Azo Compounds; Berberine; Carcinoma, Squamous Cell; Chromosome Aberrations; Crystallography, X-Ray; Databases, Factual; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Humans; Mouth Neoplasms; Neoplasm Proteins; Nucleic Acid Hybridization; Polymorphism, Single Nucleotide; Prognosis; Protein Kinase Inhibitors; Quinazolines; Risk Factors; Smoking; Stilbenes; Structure-Activity Relationship | 2007 |
1 other study(ies) available for erlotinib hydrochloride and 3,3',4,5'-tetrahydroxystilbene
| Article | Year |
|---|---|
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Biomarkers, Tumor; Enzyme Activation; Erlotinib Hydrochloride; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Microscopy, Electron; Microscopy, Fluorescence; Microtubule-Associated Proteins; Phosphorylation; Pyrimidines; Quinazolines; Signal Transduction; Sirolimus; src-Family Kinases; Stilbenes; TOR Serine-Threonine Kinases | 2011 |